首页> 外文期刊>European journal of human genetics: EJHG >p.R270X MECP2 mutation and mortality in Rett syndrome.
【24h】

p.R270X MECP2 mutation and mortality in Rett syndrome.

机译:Rett综合征中p.R270X MECP2突变和死亡率。

获取原文
获取原文并翻译 | 示例
           

摘要

Among cases in the Australian Rett Syndrome Database, the nonsense mutation p.R270X is one of the most commonly occurring single pathogenic MECP2 mutations. In two recent published reports of the MECP2 mutational spectrum the p.R270X appeared to be under represented. We hypothesised that increased mortality arising from this mutation may underlie this apparent discrepancy. We investigated our hypothesis in two independent study groups from Australia and the UK with prospective data collections (total n=524). Only females with Rett syndrome and an identified MECP2 mutation were included. Significant differences in survival were detected among Rett syndrome cases grouped for the eight most frequent mutations (log-rank chi(2) (7)=15.71, P=0.03). Moreover, survival among cases with p.R270X, when compared with survival among cases with all the other mutations was reduced (log-rank chi(2) (2)=6.94, P=0.01). Our observation of a reduced survival associated with the p.R270X mutation offers an explanation for the under representation of p.R270X in older subjects with Rett syndrome.
机译:在澳大利亚瑞特综合症数据库中,无意义的突变p.R270X是最常见的单一病原性MECP2突变之一。在最近发表的两篇有关MECP2突变谱的报告中,p.R270X的代表性不足。我们假设这种突变引起的死亡率增加可能是这种明显差异的基础。我们在来自澳大利亚和英国的两个独立研究组中调查了我们的假设,并收集了前瞻性数据(总n = 524)。仅包括患有Rett综合征且已鉴定出MECP2突变的女性。在针对八个最常见突变分组的Rett综合征病例中,发现生存率存在显着差异(对数秩chi(2)(7)= 15.71,P = 0.03)。此外,与所有其他突变患者的生存率相比,p.R270X患者的生存率降低了(对数秩chi(2)(2)= 6.94,P = 0.01)。我们观察到与p.R270X突变相关的生存期缩短,这为患有雷特综合征的老年受试者中p.R270X的代表性不足提供了一个解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号